These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9625846)

  • 1. The effect of hydrazine sulfate on prostate cancer growth.
    Kamradt JM; Pienta KJ
    Oncol Rep; 1998; 5(4):919-21. PubMed ID: 9625846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
    Naik HR; Lehr JE; Pienta KJ
    Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].
    Filov VA; Burova TM
    Biull Eksp Biol Med; 1984 Jan; 97(1):73-4. PubMed ID: 6692028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.
    Sarosdy MF; Higdon AL; Demoor CA
    J Urol; 1996 Jun; 155(6):2085-9. PubMed ID: 8618341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bropirimine immunotherapy of rodent prostate cancer.
    Sarosdy MF
    Eur Urol; 1997; 31 Suppl 1():5-9. PubMed ID: 9076480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.
    Nguyen NM; Lehr JE; Pienta KJ
    Anticancer Res; 1993; 13(6A):2143-7. PubMed ID: 7507655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
    Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A
    J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model.
    Pilat MJ; Lehr JE; Quigley MM; Pienta KJ
    Oncol Rep; 1998; 5(4):889-92. PubMed ID: 9625839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
    Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrazine sulfate in the treatment of cancer.
    Gold J
    Cancer Treat Rep; 1976 Jul; 60(7):964-5. PubMed ID: 1009532
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.
    Tiwari RK; Geliebter J; Garikapaty VP; Yedavelli SP; Chen S; Mittelman A
    Int J Oncol; 1999 Apr; 14(4):713-9. PubMed ID: 10087319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of gemcitabine in combination with other chemotherapeutic agents as an effective treatment for prostate cancer.
    Muenchen HJ; Quigley MM; Pilat MJ; Lehr JE; Brumfield SK; Mahoney M; Pienta KJ
    Anticancer Res; 2000; 20(2A):735-40. PubMed ID: 10810348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
    Dandekar DS; Lokeshwar VB; Cevallos-Arellano E; Soloway MS; Lokeshwar BL
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prostate cancer growth by vinblastine and tamoxifen.
    Pienta KJ; Replogle T; Lehr JE
    Prostate; 1995 May; 26(5):270-4. PubMed ID: 7753712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
    Nguyen NM; Lehr JE; Shelley CI; Andersen JC; Pienta KJ
    Anticancer Res; 1993; 13(6A):2053-8. PubMed ID: 7507653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R; Djakiew D
    J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.